NCT00284271已完成2 期
Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 65
- 试验地点
- 2
研究概览
简要总结
This study is designed to test (1) feasibility and efficiancy of new BACOPP regimen and (2) toxicity, overall response and FFTF.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 61 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hodgkin´s lymphoma (histologically proven)
- •CS (PS) I and II with one of the risk factors a-d
- •bulky mediastinal mass (> 1/3 maximum transverse thorax diameter)
- •extranodal involvement
- •ESR > 50 (A), > 30 (B-symptoms)
- •3 or more lymph node areas involved
- •CS (PS) III and IV
- •Written informed consent
排除标准
- •Leukocytes <3000/microl
- •Platelets <100000/microl
- •Hodgkin´s Disease as "composite lymphoma"
- •Activity index (WHO) < grade 2
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic DermatitisModerate-to-severe Atopic DermatitisNCT04444752Suzhou Connect Biopharmaceuticals, Ltd.226
已完成
3 期
Pharmacokinetic, Efficacy and Safety of BT524 in Patients With Congenital Fibrinogen DeficiencyCongenital AfibrinogenemiaCongenital HypofibrinogenemiaNCT02065882Biotest67
已完成
1 期
Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid LeukemiaAcute Myeloid LeukemiaAMLNCT03844997Sudipto Mukherjee35
终止
早期 1 期
Efficacy and Safety Evaluation of BZ371B in ARDS PatientsARDSARDS, HumanPulmonary DiseaseNCT05384379Biozeus Biopharmaceutical S.A.1
已完成
1 期
Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy AdultsHealthy Adult SubjectsNCT04811469Connect Biopharma Australia Pty Ltd74